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Several neutralizingmousemonoclonal antibodies (MAbs) specific to gly-
coprotein E of TBE virus were tested in the model animal protection
experiments using lethal doses of this virus. Mouse MAb demonstra-
ted protective activity in the absence of antibody dependent enhancement
was selected. Variable domains of this mouse Mab and constant domains
of human immunoglobulin were used to construct humanized antibody.
This humanized antibody produced by CHO cell line shown nanomolar
affinity and ability to neutralize TBE infectivity in vitro. Moreover, this
antibody demonstrated protective activity when administrated 1 2 3 days
before infection and therapeutic activity when administrated 1 2 days post
infection in TBE virus infected mice, and this activity was higher than
therapeutic activity of commercially available specific immunoglobulin
from donor blood.
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Targets for human cytomegalovirus (HCMV) miRNAs in host transcrip-
tome are still largely unknown. Aim of this study was to characterize the
effects of HCMV miRNAs on host human miRNA and mRNA tempo-
ral expression profiles after infection, identifying candidate gene targets.
To this aim, tandem microarray analysis of miRNA and mRNA temporal
expression was done in time series of MRC 5 cells infected with HCMV
Towne strain. The majority of HCMVmiRNAs was found to be expressed
since the earliest stages or within 24 hours post infection and continued
to accumulate over time. Differentially expressed mRNAs were selected
according to the area of the region bounded by the expression profiles
related to control and post infection cases. Identification of HCMV miR-
NAs targets was done by integrating the prediction of sequence based
algorithms with Pearson correlation between viral miRNAs and cellular
mRNAs temporal profile to detect significant negatively correlated target
genes. This method, for instance, permitted to identify 55 significantly
correlated target for HCMV miR US25 2 5p among the 1034 sequence
based selected candidate genes. Experimental validation of some selected
predicted targets was done by standard lucyferase activity assays and wes-
tern blot analysis. In conclusion, an integrated analysis of viral miRNAs
and host mRNA using a meta consensus approach based both on sequence
prediction methods and on correlation analysis of dynamic expression
data allowed the prediction and identification of host targets for HCMV
miRNAs.
REF O11
Non liposomal delivery of anti rabies virus siRNAs counteracts viral
growth and spread in vitro
Tobias HALBACH, Johannes HARDER, Konstantin SPARRER,
Thomas CARELL, Karl Klaus CONZELMANN
LMU, Munich, GERMANY
<tobi.halbach@gmx.de>
Rabies virus (RABV) infection continues to be a threat throughout the
world, with more than 55,000 human deaths each year. The majority of
rabies cases occur in rural regions of Africa and South Asia, where RABV
infection is endemic and access to rapid medical treatment is hindered.
After the first symptoms of rabies emerge, post exposure treatment and
vaccinations are not potent anymore and the outcome of the disease is
almost exclusively fatal. Therefore, the need for an efficient antiviral the-
rapy against rabies is still a major issue. RNA interference (RNAi), which
silences expression of specific target genes could represent a promising
tool for treating RABV infections in mammalian hosts. However, diffi-
culties including delivery of siRNA/miRNA, short term efficiency, the
emergence of resistant subpopulations and the resistance of viral RNPs
against RNAi limit the potential of this method. Here, we developed a
novel non liposomal siRNA delivery system that can counteract RABV
growth and spread in vitro. Using siRNAs that were covalently linked to
an arachidonoyl ethanol amide (anandamide) ligand via their 3‘end we
could specifically target cells expressing the receptor for the anandamide
ligand (the cannabinoid receptor), which is predominantly present on neu-
ronal and immune cells. Indeed, RABV infected human immune cells and
mouse neuronal cells that were treated with the anandamide modified siR-
NAs showed a strong inhibitory effect against RABV infection. Adapting
this system to an in vivo model, it might represent a promising tool to limit
RABV infections in vivo.
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Searching for stimulators of the innate antiviral response is an appealing
approach to develop novel therapeutics against viral infections. Here we
established a cell based reporter assay to identify compounds stimulating
expression of interferon inducible antiviral genes. We screened a total of
41,353 small molecules and selected DD264 for its immuno stimulatory
and antiviral properties. While searching for its mode of action, we iden-
tified DD264 as an inhibitor of pyrimidine biosynthesis, establishing a
yet unsuspected link between this pathway and the expression of anti-
viral genes. Furthermore, we found that antiviral activity of DD264 or
brequinar, a well known inhibitor of pyrimidine biosynthesis pathway, is
strictly dependent on cellular gene transcription and required Interferon
Regulatory Factor 1 (IRF1). Altogether, our results better explain the anti-
viral property of pyrimidine biosynthesis inhibitors and unravel a novel
pathway that induces cell resistance to RNA virus infections.
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